In the context of vaccines manufactured to prevent COVID-19 pandemic, consider the following statements:
1. The Serum Institute of India produced COVID-19 vaccine named Covishield using mRNA platform.
2. Sputnik V vaccine is manufactured using vector based platform.
3. COVAXIN is an inactivated pathogen based vaccine.
Which of the statements given above are correct?
Solution :
The correct option is 2 and 3 only.
Here is the step-by-step breakdown of why statements 2 and 3 are correct, while statement 1 is incorrect:
Statement 1 is incorrect:
Covishield was manufactured by the Serum Institute of India (under license from AstraZeneca and the University of Oxford). However, it is not an mRNA-based vaccine. Covishield is a viral vector vaccine that uses a weakened, modified chimpanzee adenovirus (ChAdOx1) to deliver the genetic code of the SARS-CoV-2 spike protein into human cells. In contrast, mRNA vaccines (like those developed by Pfizer-BioNTech and Moderna) use messenger RNA molecules wrapped in lipid nanoparticles to deliver genetic instructions.
Statement 2 is correct:
Sputnik V, developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia, is manufactured using a viral vector-based platform. It utilizes two different human adenoviruses (Ad26 for the first dose and Ad5 for the second dose) as vectors to carry the gene for the SARS-CoV-2 spike protein into the body, triggering an immune response.
Statement 3 is correct:
COVAXIN, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV), is an inactivated pathogen-based vaccine. It uses dead (inactivated) SARS-CoV-2 viruses. Since the pathogen is inactivated, it cannot replicate or cause COVID-19, but it still trains the immune system to recognize and fight the live virus.
Therefore, statements 2 and 3 are correct, making "2 and 3 only" the correct answer choice.
Completely free for students. Educators & coaching institutes get 2 months free Pro trial to create tests.
Access unlimited practice questions, detailed step-by-step solutions, and exam study materials — completely free for students.
Create and conduct professional online assessments with AI question generation, tab proctoring, and comprehensive batch management.
RRB JE CBT 1 20-02-2026 Shift 3 Question Paper with Solution in PDF format. This paper is highly useful for candidates preparing for upcoming Railway Recruitment Board (RRB) Junior Engineer (JE) examinations. It contains the complete Shift 3 question paper conducted on 20 February 2026, along with detailed solutions and explanations. Analyze the latest exam pattern, question trends, difficulty level, and important topics asked in the examination. This solved paper will help aspirants understand the types of questions asked in Mathematics, General Intelligence & Reasoning, General Science, and General Awareness sections. By practicing this paper, candidates can assess their preparation level, identify weak areas, and improve their exam strategy for future RRB JE examinations. A valuable study resource for RRB JE aspirants aiming to maximize their scores in CBT 1 and secure selection in the next stage of the recruitment process.
RRB JE CBT 1 25-02-2026 Shift 3 Question Paper with Solution in PDF format. This paper is highly useful for candidates preparing for upcoming Railway Recruitment Board (RRB) Junior Engineer (JE) examinations. It contains the complete Shift 3 question paper conducted on 25 February 2026, along with detailed solutions and explanations. Analyze the latest exam pattern, question trends, difficulty level, and important topics asked in the examination. This solved paper will help aspirants understand the types of questions asked in Mathematics, General Intelligence & Reasoning, General Science, and General Awareness sections.
Copyright © 2026 Combe Labs Private Limited. All Rights Reserved.